FDA Approves New Fully Liquid Presentation of GSK ’s Rotarix Vaccine to Prevent Gastroenteritis Caused by Rotavirus

New fully liquid formulation of Rotarix removes the need to reconstitute prior to administration, for improved convenience Clinical data demonstrated non-inferiority of immunogenicity as compared to the lyophilized formulation of Rotarix and...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news